Navigation Links
Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
Date:3/23/2010

;s.linkTrackVars='prop5,eVar3,prop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='88900072';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.oncothyreon.com">www.oncothyreon.com. An archive of the webcast will be available after completion of the discussion and will be posted on the Oncothyreon website.

About Stimuvax

Merck KGaA has an exclusive world-wide license from Oncothyreon for Stimuvax. Merck KGaA is investigating the use of Stimuvax(R) (BLP25 liposome vaccine) in the treatment of NSCLC. The vaccine was granted fast-track status in September 2004 by the FDA. Stimuvax is being developed in Europe by Merck KGaA and in the United States by its affiliate, EMD Serono Inc.

START is a multi-center, randomized, double-blind, placebo-controlled Phase 3 study that will evaluate patients with documented unresectable stage IIIA or IIIB NSCLC who have had a response or stable disease after at least two cycles of platinum-based chemo-radiotherapy. The study will involve more than 1,300 patients in approximately 30 countries.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement
2. Oncothyreons PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
3. Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
4. Oncothyreon announces webcast of third quarter 2009 financial results conference call
5. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
6. Oncothyreon to present at Rodman Renshaw Global Healthcare Conference
7. Oncothyreon reports second quarter 2009 financial results
8. Oncothyreon announces closing of $15.0 million registered direct financing
9. Oncothyreon announces webcast of second quarter 2009 financial results conference call
10. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
11. Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Neurotrope, Inc. (OTCQB: NTRP) ... call to provide an update on Company activities. ... timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or (719) ... www.neurotropebioscience.com , under "Investor Relations"The teleconference replay will ... September 2, 2014 at (888) 203-1112 (U.S. and ...
(Date:8/20/2014)... 2014 High performance computing (HPC) ... most complete climate and Earth system model to ... issues. , Eight national laboratories, including Lawrence ... Center for Atmospheric Research, four academic institutions and ... participating national laboratories include Argonne, Brookhaven, Lawrence Berkeley, ...
(Date:8/20/2014)... Group finds that the vascular access device market in ... and China (BRIC) was valued ... of the United States market that year. ... as a result of strong economic expansion, improving access to healthcare ... Resources Group,s coverage of the BRIC vascular access device market: ...
(Date:8/20/2014)... 20, 2014  PAREXEL International Corporation (NASDAQ: ... at the Baird Healthcare Conference in New York.  ... Officer, will be making a presentation on PAREXEL and ... Sept. 3, 2014. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
Breaking Biology Technology:Neurotrope To Host Conference Call 2New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3PAREXEL International To Present At Baird Healthcare Conference 2
... , ... that a new market research report is available in ... Market Report , http://www.reportlinker.com/p0164431/Industrial-Enzymes---A-Global-Market-Report.html , Industrial ... and a host of small suppliers engaged in niche ...
... , Former Majority Leader Richard Gephardt Brings Together A-List ... and Brightest Forum on Medical Innovation" , JERSEY ... prominent leaders in biopharmaceuticals, research, medicine and technology gathered today ... medical innovation in New Jersey, and throughout the United States. ...
... FRANCISCO, Dec. 1 The Burrill Biotech Select Index managed to ... Select,s gain of 4.5 percent mirrored what was also an excellent ... and the NASDAQ up 4.8 percent in value. The gains held ... investor worries about sluggish Thanksgiving holiday shopping and Dubai,s reported debt ...
Cached Biology Technology:Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
(Date:8/20/2014)... 20, 2014 /CNW/ -  Issue Serious ... quickly become life threatening for some children.    ... million Canadians have food allergies and this number may be ... children are estimated to have food allergies.  ... irritations and hives to breathing difficulties and loss of consciousness. ...
(Date:8/20/2014)... of Tbingen, Arizona State University, the Wellcome Trust Sanger ... (Swiss TPH) isolated Mycobacterium pinnipedii from skeletons ... old. The pathogen is a relative of the TB ... in humans today. These researchers assume that seals carried ... link to sea lions was unexpected" comments Sebastien Gagneux, ...
(Date:8/20/2014)... this image of the Para and Mato Grosso states ... intentionally set in order to deforest the land. Deforestation ... trees where the land is thereafter converted to a ... to farms, ranches, or urban use. The herringbone-patterned tan ... Rainforest in the middle of the image are evidence ...
Breaking Biology News(10 mins):Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
... new insight into the impact that warmer temperatures could have ... Mary, University of London. The research, published in the ... that the impact of global warming could be similar across ... team, based at Queen Mary,s School of Biological and Chemical ...
... Inc. ("CTI") (NASDAQ and MTA: CTIC) announced today that, ... for Medicinal Products for Human Use ("CHMP"), the CHMP ... ("MAA") for Pixuvri in mid-February. In the interim, CTI ... Summary of Product Characteristics and other labeling items for ...
... A comprehensive multi-disciplinary synthesis just published in Environmental ... and policy development to address significant environmental, social and ... change. "Effects of climate change on the distribution ... of range change prediction in a warming world" is ...
Cached Biology News:Ecologists gain insight into the likely consequences of global warming 2Cell Therapeutics, Inc. Expects That the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri™ in Mid-February 2Cell Therapeutics, Inc. Expects That the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri™ in Mid-February 3Climate change invites alien invaders Is Canada ready? 2
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
Human RELT/TNFRSF19L MAb (Clone 238104)...
homeo box D3, mRNA...
Human TSLP MAb (Clone 258136)...
Biology Products: